by Amy DuRoss | July 30, 2019
While every day we seek to bring kaizen to cell and gene therapy, we still have an important first step to accomplish as an industry (as we all know) -- standardization. Without standardization, we can’t optimize or achieve truly “lean”…
by Marc Puich | July 10, 2019
Previously in this series, we discussed the Strategy, the Operational Ecosystem, and the Processes needed to establish an effective personalized medicine supply chain. Now, we’ll turn our attention to one more essential component -- managing risks…
by Heidi Hagen | June 19, 2019
In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before -- and it’s also more complex. We’ve been working with other industry leaders on new and updated standards for cell and gene…
by Heidi Hagen | June 12, 2019
At the recent ISCT 2019 annual meeting, Heidi Hagen from Vineti was invited to speak on the topic of cell therapy data management. Here are a few highlights from her presentation.
by Marc Puich | June 4, 2019
Success depends on defining and communicating broadly all facets of the therapy’s “real world” process requirements.